Springe zum Inhalt

Drug delivery to retinal photoreceptors


The photoreceptors of the retina are afflicted by diseases that still often lack satisfactory treatment options. Although suitable drugs might be available in some cases, the delivery of these compounds into the eye and across the blood–retinal barrier remains a significant challenge for therapy development. Here, we review the routes of drug administration to the retina and highlight different options for drug delivery to the photoreceptor cells.

zum Beitrag (extern)

4 Gedanken zu „Drug delivery to retinal photoreceptors

  1. J. Repetto

    Hi, I'd like to have more information on HJMD and its treatments. Has the Ataulauren produced any positive results?

    1. Matze

      Unfortunately, there is no explicit efficacy study in HJMD with any kind of read-through drug.
      In the Moorfields Eye Hospital London is Mrs. Mariya Moosajee and in Mainz Germany the group Wolfrum have already published a lot here.
      Of course, there is a lack of money - what a pity, because with a functioning substance, one could effectively treat a great many genetic diseases with it.

      1. Jonathan Repetto

        Thanks for the reply. In Italy, I followed a case of HJMD through the Gaslini hospital in Genoa where a sample of the patient's cells was treated with Ataulauren at the Catanzaro laboratory. Unfortunately, there have been no positive feedbacks to date. Do you have any tips to limit macular degeneration?


Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert

I accept that my given data and my IP address is sent to a server in the USA only for the purpose of spam prevention through the Akismet program.More information on Akismet and GDPR.

Diese Website verwendet Akismet, um Spam zu reduzieren. Erfahre mehr darüber, wie deine Kommentardaten verarbeitet werden.